639.DU
Spotify Technology SA
DusseldorfEUREQUITY
DELAYED
Last price
461.00
▲ 1.50 (0.33%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
461.00
Prev close
459.50
Day high
461.00
Day low
461.00
Volume
0
Market cap
—
P/E (TTM)
—
52W range
345.45 – 627.80
Day trading desk
Gap from prior close
+0.77%
Prior close 457.50
VWAP
—
—
Relative volume
—
—
Session range
—
461.00 – 461.00
Position in range
—
—
ATR (14D)
13.25
2.87% of price
Prior day high
457.50
PDH
Prior day low
455.50
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+7.33%
+8.5%
1M
+8.85%
+5.5%
3M
+4.30%
+1.9%
6M
+16.83%
+4.9%
YTD
-6.52%
-18.5%
1Y
-22.97%
-43.1%
3Y
+241.99%
+167.0%
5Y
+122.38%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 639.DU open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $17.19B | $15.67B | $13.25B | $11.73B | +9.7% |
| Operating revenue | $17.19B | $15.67B | $13.25B | $11.73B | +9.7% |
| Cost of revenue | $11.69B | $10.95B | $9.85B | $8.80B | +6.8% |
| Gross profit | $5.50B | $4.72B | $3.40B | $2.93B | +16.3% |
| Research & development | $1.39B | $1.49B | $1.73B | $1.39B | -6.3% |
| Selling, general & admin | $1.91B | $1.87B | $2.12B | $2.20B | +1.7% |
| Total operating expense | $3.30B | $3.36B | $3.84B | $3.58B | -1.8% |
| Operating income | $2.20B | $1.36B | -$446.00M | -$659.00M | +61.0% |
| Net interest income | $226.00M | $199.00M | $93.00M | $2.00M | +13.6% |
| Pre-tax income | $2.22B | $1.34B | -$505.00M | -$370.00M | +65.8% |
| Tax provision | $12.00M | $203.00M | $27.00M | $60.00M | -94.1% |
| Net income | $2.21B | $1.14B | -$532.00M | -$430.00M | +94.4% |
| Net income to common | $2.21B | $1.14B | -$532.00M | -$430.00M | +94.4% |
| Basic EPS | 10.77 | 5.67 | -2.73 | -2.23 | +89.9% |
| Diluted EPS | 10.51 | 5.50 | -2.73 | -2.93 | +91.1% |
| EBIT | $2.25B | $1.38B | -$467.00M | -$329.00M | +63.8% |
| EBITDA | $2.36B | $1.50B | -$309.00M | -$158.00M | +57.3% |
| Basic shares | 205.41M | 200.62M | 194.73M | 192.93M | +2.4% |
| Diluted shares | 210.51M | 206.99M | 194.73M | 195.85M | +1.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.26B | $4.78B | $3.11B | $2.48B | — | +10.0% |
| Cash & short-term investments | $9.47B | $7.45B | $4.21B | $3.35B | — | +27.1% |
| Accounts receivable | $536.00M | $540.00M | $602.00M | $502.00M | — | -0.7% |
| Total current assets | $10.50B | $8.38B | $5.26B | $4.35B | — | +25.3% |
| Property, plant & equipment | $422.00M | $414.00M | $547.00M | $765.00M | — | +1.9% |
| Goodwill & intangibles | $1.12B | $1.25B | $1.22B | $1.29B | — | -10.0% |
| Total assets | $15.02B | $12.01B | $8.35B | $7.64B | — | +25.1% |
| Total current liabilities | $6.08B | $4.45B | $4.09B | $3.52B | — | +36.7% |
| Current debt | $1.46B | — | — | — | — | — |
| Long-term debt | — | $1.54B | $1.20B | $1.13B | $1.20B | — |
| Total debt | $1.96B | $2.08B | $1.70B | $1.68B | — | -5.8% |
| Total liabilities | $6.69B | $6.48B | $5.82B | $5.24B | — | +3.2% |
| Retained earnings | -$832.00M | -$3.04B | -$4.18B | -$3.65B | — | +72.7% |
| Shareholder equity | $8.33B | $5.53B | $2.52B | $2.40B | — | +50.8% |
| Working capital | $4.41B | $3.93B | $1.17B | $836.00M | — | +12.3% |
| Net tangible assets | $7.21B | $4.28B | $1.30B | $1.11B | — | +68.5% |
| Shares issued | 209.49M | 207.48M | 201.34M | 196.86M | — | +1.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.21B | $1.14B | -$532.00M | -$430.00M | +94.4% |
| Depreciation & amortisation | $102.00M | $121.00M | $158.00M | $171.00M | -15.7% |
| Stock-based compensation | $247.00M | $267.00M | $321.00M | $381.00M | -7.5% |
| Change in working capital | $248.00M | $376.00M | $464.00M | $191.00M | -34.0% |
| Operating cash flow | $2.93B | $2.30B | $680.00M | $46.00M | +27.5% |
| Capital expenditure | -$61.00M | -$17.00M | -$6.00M | -$25.00M | -258.8% |
| Investing cash flow | -$1.78B | -$1.49B | -$217.00M | -$423.00M | -20.1% |
| Share buybacks | -$439.00M | $0 | $0 | -$2.00M | — |
| Financing cash flow | -$381.00M | $729.00M | $234.00M | -$40.00M | -152.3% |
| Free cash flow | $2.87B | $2.28B | $674.00M | $21.00M | +25.7% |
| End cash position | $5.26B | $4.78B | $3.11B | $2.48B | +10.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $4.78B | $4.53B | $4.53B | $4.27B | $4.19B | — | +5.4% |
| Operating revenue | $4.78B | $4.53B | $4.53B | $4.27B | $4.19B | — | +5.4% |
| Cost of revenue | $3.18B | $3.04B | $3.03B | $2.92B | $2.87B | — | +4.7% |
| Gross profit | $1.60B | $1.50B | $1.50B | $1.35B | $1.32B | — | +6.8% |
| Research & development | $403.00M | $331.00M | $290.00M | $309.00M | $415.00M | — | +21.8% |
| Selling, general & admin | $538.00M | $449.00M | $508.00M | $460.00M | $499.00M | — | +19.8% |
| Total operating expense | $941.00M | $780.00M | $798.00M | $769.00M | $914.00M | — | +20.6% |
| Operating income | $655.00M | $715.00M | $701.00M | $582.00M | $406.00M | — | -8.4% |
| Net interest income | $49.00M | $56.00M | $57.00M | $56.00M | $56.00M | — | -12.5% |
| Pre-tax income | $720.00M | $937.00M | $1.02B | $827.00M | $48.00M | — | -23.2% |
| Tax provision | $175.00M | $216.00M | -$153.00M | -$72.00M | $134.00M | — | -19.0% |
| Net income | $545.00M | $721.00M | $1.17B | $899.00M | -$86.00M | — | -24.4% |
| Net income to common | $545.00M | $721.00M | $1.17B | $899.00M | -$86.00M | — | -24.4% |
| Basic EPS | 2.65 | 3.50 | 5.71 | — | -0.42 | 1.10 | -24.3% |
| Diluted EPS | 2.61 | 3.45 | 4.43 | — | -0.42 | 1.07 | -24.3% |
| EBIT | $728.00M | $944.00M | $1.03B | $835.00M | $56.00M | — | -22.9% |
| EBITDA | $757.00M | $970.00M | $1.05B | $859.00M | $82.00M | — | -22.0% |
| Basic shares | 205.79M | 205.72M | 205.77M | — | 205.43M | 204.47M | +0.0% |
| Diluted shares | 208.86M | 209.28M | 212.49M | — | 205.43M | 210.24M | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5.94B | $5.25B | $5.26B | $5.46B | $5.16B | — | +13.0% |
| Cash & short-term investments | $9.39B | $8.75B | $9.47B | $9.06B | $8.34B | — | +7.3% |
| Accounts receivable | $543.00M | $463.00M | $536.00M | $511.00M | $509.00M | — | +17.3% |
| Total current assets | $10.38B | $9.66B | $10.50B | $10.06B | $9.30B | — | +7.4% |
| Property, plant & equipment | $418.00M | $409.00M | $422.00M | $416.00M | $417.00M | — | +2.2% |
| Goodwill & intangibles | $1.15B | $1.14B | $1.12B | $1.11B | $1.11B | — | +0.5% |
| Total assets | $13.75B | $13.13B | $15.02B | $14.69B | $13.46B | — | +4.7% |
| Total current liabilities | $4.91B | $4.69B | $6.08B | $6.24B | $6.31B | — | +4.8% |
| Current debt | — | — | $1.46B | $1.74B | $1.93B | $1.65B | — |
| Long-term debt | — | — | — | — | — | — | — |
| Total debt | $466.00M | $476.00M | $1.96B | $2.25B | $2.38B | — | -2.1% |
| Total liabilities | $5.36B | $5.12B | $6.69B | $6.91B | $6.84B | — | +4.8% |
| Retained earnings | $421.00M | -$124.00M | -$832.00M | -$2.01B | -$2.90B | — | +439.5% |
| Shareholder equity | $8.38B | $8.01B | $8.33B | $7.78B | $6.63B | — | +4.7% |
| Working capital | $5.46B | $4.97B | $4.41B | $3.82B | $2.99B | — | +9.9% |
| Net tangible assets | $7.24B | $6.87B | $7.21B | $6.67B | $5.52B | — | +5.4% |
| Shares issued | 205.58M | 209.74M | 209.49M | 208.99M | 208.49M | — | -2.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $545.00M | $721.00M | $1.17B | $899.00M | -$86.00M | -24.4% |
| Depreciation & amortisation | $29.00M | $26.00M | $25.00M | $24.00M | $26.00M | +11.5% |
| Stock-based compensation | $86.00M | $56.00M | $57.00M | $75.00M | $73.00M | +53.6% |
| Change in working capital | $89.00M | $29.00M | $24.00M | $101.00M | $202.00M | +206.9% |
| Operating cash flow | $816.00M | $836.00M | $856.00M | $829.00M | $709.00M | -2.4% |
| Capital expenditure | -$20.00M | -$5.00M | -$22.00M | -$23.00M | -$10.00M | -300.0% |
| Investing cash flow | $62.00M | $732.00M | -$629.00M | -$438.00M | -$404.00M | -91.5% |
| Share buybacks | -$232.00M | -$306.00M | -$381.00M | -$58.00M | $0 | +24.2% |
| Financing cash flow | -$218.00M | -$1.61B | -$418.00M | -$100.00M | $11.00M | +86.5% |
| Free cash flow | $796.00M | $831.00M | $834.00M | $806.00M | $699.00M | -4.2% |
| End cash position | $5.94B | $5.25B | $5.26B | $5.46B | $5.16B | +13.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
444.10
+3.81% from price
SMA 20
438.70
+5.08% from price
SMA 50
424.15
+8.69% from price
SMA 100
418.15
+10.25% from price
SMA 200
437.62
+5.34% from price
EMA 12
445.95
+3.38% from price
EMA 26
437.17
+5.45% from price
EMA 50
429.92
+7.23% from price
RSI (14)
60.6
Neutral
MACD (12,26,9)
8.77
Hist 2.98
ATR (14)
13.25
2.87% of price
Realised vol 30D
36.8%
Annualised
Bollinger upper
469.69
20, 2σ
Bollinger lower
407.71
20, 2σ
50 / 200 cross
Death
424.15 vs 437.62
Trend bias
Above 200
+5.34%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.05
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
36.8%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-44.1%
Peak to trough
Max drawdown 5Y
-73.6%
Peak to trough
ATR 14
13.25
2.87% of price
Beta (reported)
—
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 26 | Argus Research | MAINTAINED | Buy | Buy |
| Aug 5, 26 | Cantor Fitzgerald | MAINTAINED | Neutral | Neutral |
| Aug 5, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Aug 5, 26 | Rosenblatt | MAINTAINED | Neutral | Neutral |
| Jul 22, 26 | Benchmark | MAINTAINED | Buy | Buy |
| Jul 10, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 9, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 9, 26 | Rosenblatt | MAINTAINED | Neutral | Neutral |
| May 26, 26 | Cantor Fitzgerald | MAINTAINED | Neutral | Neutral |
| May 22, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| May 22, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| May 22, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
Headlines
Tech Weekly: running robots, reusable rockets
Reuters Videos · 7m ago
Net Asset Value(s)
Business Wire · 9m ago
AstraZeneca prices €2.55bn euro bond sale across four tranches
Proactive · 10m ago
Trees 'giving up': climate change hammers historic English gardens
AFP · 13m ago
Implantica to host Capital Markets Day in Stockholm on September 9
PR Newswire · 13m ago
Saudi Arabia to fund three new theme parks near Paris
Euronews · 14m ago
Cadeler: Q2 Earnings Snapshot
Associated Press · 15m ago
Solvonis raises £1.3m to fund three clinical programmes
Proactive · 15m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.